Investigators at Ufa Institute of Chemistry Describe Findings in Life Science (Messagenin-based Chalcones: Synthesis, Modification and Perspectives of Antidiabetic Potency).
In: Diabetes Week, 2024-05-06, S. 128
serialPeriodical
Zugriff:
A recent report from the Ufa Institute of Chemistry in Ufa, Russia discusses the synthesis and potential antidiabetic properties of messagenin-based chalcones. These compounds were found to act as alpha-glucosidase inhibitors, with one particular compound showing promising results in animal models of diabetes. The research suggests that this compound may have potential for improving diabetic nephropathy and reducing diabetes-related mortality. The study was supported by Federal Programs and has been peer-reviewed. For more information, readers can refer to the article "Messagenin-based Chalcones: Synthesis, Modification and Perspectives of Antidiabetic Potency" in the Asian Journal of Organic Chemistry. [Extracted from the article]
Copyright of Diabetes Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Investigators at Ufa Institute of Chemistry Describe Findings in Life Science (Messagenin-based Chalcones: Synthesis, Modification and Perspectives of Antidiabetic Potency).
|
---|---|
Zeitschrift: | Diabetes Week, 2024-05-06, S. 128 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1537-1425 (print) |
Sonstiges: |
|